Percutaneous patent foramen ovale closure for hypoxaemia at the age of 73: a case report showing immediate benefit

European Heart Journal - Case Reports

16 August 2024
Organised by: Logo
ESC Journals Interventional Cardiology

Abstract

AbstractBackground

Approximately 25% of the general population has a patent foramen ovale (PFO) that remains asymptomatic in the vast majority. Right-to-left shunt (RLS)-mediated hypoxaemia is a rare associated condition of PFO.

Case summary

This report describes a case of percutaneous PFO closure for hypoxaemia in a 73-year-old patient showing immediate clinical benefit. She experienced progressive dyspnoea on exertion requiring oxygen therapy. SaO2 was 87% at rest without oxygen therapy, which increased to 98% after percutaneous PFO closure.

Discussion

Most PFOs remain clinically insignificant but RLS-mediated hypoxaemia is a rare phenomenon that can occur even at advanced age. Percutaneous PFO closure is a safe and effective therapy option that provides immediate improvement of hypoxaemia.

Contributors

Berto J Bouma
Berto J Bouma

Author

Amsterdam University Medical Centre (AUMC) Amsterdam , Netherlands (The)

Marcel A M Beijk
Marcel A M Beijk

Author

Amsterdam University Medical Centre (AUMC) Amsterdam , Netherlands (The)

ESC 365 is supported by